webinar register page

Perspectives on Minimal Residual Disease (MRD) Testing in Myeloma

Myeloma Patients Europe (MPE) will hold a panel event on “the perspectives of minimal residual disease in multiple myeloma” on Wednesday, 29 March 2023 from 15:00 - 16:30 CET.

MPE will present the findings of our research project and recommendations, followed by a panel discussion comprised of patient, clinician, research and industry representatives to discuss the issues surrounding MRD.

Find the full agenda below:

15:00 to 15:10: Welcome and Introductions
15:10 to 15:35: Presentation on MRD research.
• Silene Ten Seldam, Research assistant at Myeloma Patients Europe
15:35 to 16:15: Panel Discussion
Moderator: Eric Low, Eric Low Consulting
• Hans Scheurer, Myeloma patient and Chair of the Workgroup of European Cancer Patient Advocacy Networks (WECAN)
• Dr. Martin Kaiser, Haematologist at Royal Marsden Hospital and Institute of Cancer Research, London, UK
• Dr. Bruno Paiva, Researcher at Clinica Universidad de Navarra, Spain
• Veronica Calzada, Oncology Novel Endpoints representative at European Federation of Pharmaceutical Industries and Associations (EFPIA)
• Paula B. Van Hennik, PhD, Director Regulatory Sciences, Propharma
16:15 to 16:25: Questions and Answers session
16:25 to 16:30: Closing remarks


Feel free to forward the registration link to colleagues and other patient advocates who might be interested in attending the webinar.

If you have any questions or would like to send your questions in advance, please email research@mpeurope.org, and we will make sure they reach our speakers.

A recording of the webinar will be available shortly after the session. Keep an eye out on our social media channels!

We look forward to your participation.

Mar 29, 2023 03:00 PM in Madrid